25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

000078 (Shenzhen Neptunus Bioengineering Co Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Shenzhen Neptunus Bioengineering Co Ltd together

I guess you are interested in Shenzhen Neptunus Bioengineering Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Shenzhen Neptunus Bioengineering Co Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Shenzhen Neptunus Bioengineering Co Ltd’s Price Targets

I'm going to help you getting a better view of Shenzhen Neptunus Bioengineering Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Shenzhen Neptunus Bioengineering Co Ltd

I send you an email if I find something interesting about Shenzhen Neptunus Bioengineering Co Ltd.

1. Quick Overview

1.1. Quick analysis of Shenzhen Neptunus Bioengineering Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Shenzhen Neptunus Bioengineering Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥1.59
Expected worth in 1 year
¥0.83
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
¥-0.56
Return On Investment
-22.8%

For what price can you sell your share?

Current Price per Share
¥2.45
Expected price per share
¥2.28 - ¥2.55
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Shenzhen Neptunus Bioengineering Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥2.45
Intrinsic Value Per Share
¥-6.57 - ¥-7.86
Total Value Per Share
¥-4.98 - ¥-6.27

2.2. Growth of Shenzhen Neptunus Bioengineering Co Ltd (5 min.)




Is Shenzhen Neptunus Bioengineering Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$577.4m$848.7m-$266m-45.7%

How much money is Shenzhen Neptunus Bioengineering Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$59.6m-$37.4m-$22.2m-37.3%
Net Profit Margin-5.6%-3.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Shenzhen Neptunus Bioengineering Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Shenzhen Neptunus Bioengineering Co Ltd?

Welcome investor! Shenzhen Neptunus Bioengineering Co Ltd's management wants to use your money to grow the business. In return you get a share of Shenzhen Neptunus Bioengineering Co Ltd.

First you should know what it really means to hold a share of Shenzhen Neptunus Bioengineering Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Shenzhen Neptunus Bioengineering Co Ltd is ¥2.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shenzhen Neptunus Bioengineering Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shenzhen Neptunus Bioengineering Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.59. Based on the TTM, the Book Value Change Per Share is ¥-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shenzhen Neptunus Bioengineering Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.02-0.9%-0.01-0.6%-0.01-0.3%0.000.0%
Usd Book Value Change Per Share0.010.3%-0.03-1.1%-0.02-0.6%-0.01-0.4%0.000.1%
Usd Dividend Per Share0.010.2%0.010.3%0.010.5%0.010.5%0.010.4%
Usd Total Gains Per Share0.010.5%-0.02-0.8%0.00-0.2%0.000.1%0.010.6%
Usd Price Per Share0.36-0.36-0.45-0.47-0.83-
Price to Earnings Ratio2,134.24-674.30-706.53-296.20-181.39-
Price-to-Total Gains Ratio30.08--12.29-35.30-5.97-47.59-
Price to Book Ratio1.65-1.62-1.39-1.39-4.61-
Price-to-Total Gains Ratio30.08--12.29-35.30-5.97-47.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.33761
Number of shares2961
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.020.00
Gains per Quarter (2961 shares)-56.946.22
Gains per Year (2961 shares)-227.7524.87
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
182-309-238131-10615
2163-619-466262-21240
3245-928-694393-31965
4327-1238-922524-42590
5409-1547-1150655-531115
6490-1857-1378786-637140
7572-2166-1606917-743165
8654-2476-18341048-849190
9736-2785-20621179-956215
10817-3095-22901310-1062240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%33.07.00.082.5%74.016.00.082.2%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%13.07.00.065.0%29.011.00.072.5%63.027.00.070.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%78.00.012.086.7%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%35.05.00.087.5%74.016.00.082.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Shenzhen Neptunus Bioengineering Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.048-0.190+497%-0.114+338%-0.065+236%0.023+110%
Book Value Per Share--1.5931.589+0%2.341-32%2.471-36%2.227-28%
Current Ratio--1.0431.041+0%1.064-2%1.061-2%1.115-6%
Debt To Asset Ratio--0.8660.8680%0.831+4%0.824+5%0.798+9%
Debt To Equity Ratio--8.9369.161-2%6.361+40%6.271+42%5.349+67%
Dividend Per Share--0.0390.050-22%0.086-54%0.080-51%0.078-50%
Enterprise Value---20234822484.090-19035496036.710-6%-18299749605.785-10%-17481279167.517-14%-5083935571.480-75%
Eps--0.000-0.165+53733%-0.108+35152%-0.058+18933%-0.007+2514%
Ev To Ebitda Ratio--infinfnan%-24.167nan%infnan%infnan%
Ev To Sales Ratio---0.639-0.588-8%-0.490-23%-0.466-27%0.249-357%
Free Cash Flow Per Share---0.034-0.062+82%-0.060+76%0.059-157%0.044-178%
Free Cash Flow To Equity Per Share---0.034-0.062+82%0.012-375%-0.020-40%0.007-610%
Gross Profit Margin--1.000-0.609+161%-102.936+10394%-22.737+2374%-12.755+1376%
Intrinsic Value_10Y_max---7.860--------
Intrinsic Value_10Y_min---6.569--------
Intrinsic Value_1Y_max---0.223--------
Intrinsic Value_1Y_min---0.218--------
Intrinsic Value_3Y_max---1.100--------
Intrinsic Value_3Y_min---1.041--------
Intrinsic Value_5Y_max---2.496--------
Intrinsic Value_5Y_min---2.279--------
Market Cap6446243686.400-7%6893542933.3406845809954.038+1%8537994968.965-19%9113208723.792-24%15946588811.010-57%
Net Profit Margin--0.000-0.056+54774%-0.031+30468%-0.018+17313%0.003-96%
Operating Margin---0.003-100%-0.0250%0.006-100%0.023-100%
Operating Ratio--1.8791.430+31%0.971+94%1.056+78%1.001+88%
Pb Ratio1.538-7%1.6451.620+2%1.386+19%1.391+18%4.614-64%
Pe Ratio1995.756-7%2134.237674.303+217%706.533+202%296.200+621%181.394+1077%
Price Per Share2.450-7%2.6202.578+2%3.245-19%3.386-23%6.004-56%
Price To Free Cash Flow Ratio-18.049+6%-19.30123.380-183%4.762-505%-31.974+66%-23.149+20%
Price To Total Gains Ratio28.131-7%30.083-12.291+141%35.302-15%5.974+404%47.595-37%
Quick Ratio--0.6370.723-12%0.921-31%0.894-29%0.948-33%
Return On Assets--0.000-0.013+52104%-0.007+29189%-0.004+16975%0.001-96%
Return On Equity--0.000-0.144+54338%-0.058+21896%-0.042+15777%-0.006+2407%
Total Gains Per Share--0.087-0.140+260%-0.028+132%0.015+472%0.101-14%
Usd Book Value--577449603.211582661288.182-1%848754947.208-32%916882036.901-37%821753082.730-30%
Usd Book Value Change Per Share--0.007-0.026+497%-0.016+338%-0.009+236%0.003+110%
Usd Book Value Per Share--0.2190.219+0%0.323-32%0.340-36%0.307-28%
Usd Dividend Per Share--0.0050.007-22%0.012-54%0.011-51%0.011-50%
Usd Enterprise Value---2788358538.308-2623091353.859-6%-2521705495.677-10%-2408920269.284-14%-700566321.750-75%
Usd Eps--0.000-0.023+53733%-0.015+35152%-0.008+18933%-0.001+2514%
Usd Free Cash Flow---12304080.174-22370297.679+82%-21672544.701+76%22876219.502-154%11401303.412-208%
Usd Free Cash Flow Per Share---0.005-0.009+82%-0.008+76%0.008-157%0.006-178%
Usd Free Cash Flow To Equity Per Share---0.005-0.009+82%0.002-375%-0.003-40%0.001-610%
Usd Market Cap888292379.986-7%949930216.214943352611.666+1%1176535706.723-19%1255800162.139-24%2197439938.157-57%
Usd Price Per Share0.338-7%0.3610.355+2%0.447-19%0.467-23%0.827-56%
Usd Profit--111272.804-59674614.593+53729%-37415666.937+33725%-20356673.540+18394%-2200609.690+2078%
Usd Revenue--1091548664.2741113805336.566-2%1292546796.187-16%1313734583.945-17%1074865755.126+2%
Usd Total Gains Per Share--0.012-0.019+260%-0.004+132%0.002+472%0.014-14%
 EOD+3 -5MRQTTM+26 -13YOY+16 -225Y+13 -2610Y+10 -29

3.3 Fundamental Score

Let's check the fundamental score of Shenzhen Neptunus Bioengineering Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151,995.756
Price to Book Ratio (EOD)Between0-11.538
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.637
Current Ratio (MRQ)Greater than11.043
Debt to Asset Ratio (MRQ)Less than10.866
Debt to Equity Ratio (MRQ)Less than18.936
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Shenzhen Neptunus Bioengineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.455
Ma 20Greater thanMa 502.410
Ma 50Greater thanMa 1002.433
Ma 100Greater thanMa 2002.637
OpenGreater thanClose2.410
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Shenzhen Neptunus Bioengineering Co Ltd

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, infusion products, and western medicine preparations in China. The company provides oryzanol tablets, chlorpheniramine tablets, chlorpheniramine maleate tablets, and rifampicin capsules, as well as technical support for generic drug quality consistency evaluation and other medical research and development work. It also distributes drugs, medical devices, and other medical supplies; and provides value-added services for hospitals, medical institutions, and drug retail institutions and distributors. The company offers drugs in the fields of malignant tumors, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, diabetes, infectious diseases, and multiple diseases, such as respiratory system and digestive system. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1989 and is headquartered in Shenzhen, China.

Fundamental data was last updated by Penke on 2025-03-22 20:22:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Shenzhen Neptunus Bioengineering Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that ¥0.00 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.0%. The company is not making a profit/loss.
  • The TTM is -5.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-5.6%+5.6%
TTM-5.6%YOY-3.1%-2.5%
TTM-5.6%5Y-1.8%-3.8%
5Y-1.8%10Y0.3%-2.0%
4.3.1.2. Return on Assets

Shows how efficient Shenzhen Neptunus Bioengineering Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Assets means that Shenzhen Neptunus Bioengineering Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.0%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-1.3%+1.3%
TTM-1.3%YOY-0.7%-0.6%
TTM-1.3%5Y-0.4%-0.9%
5Y-0.4%10Y0.1%-0.5%
4.3.1.3. Return on Equity

Shows how efficient Shenzhen Neptunus Bioengineering Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Shenzhen Neptunus Bioengineering Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -14.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.0%TTM-14.4%+14.5%
TTM-14.4%YOY-5.8%-8.6%
TTM-14.4%5Y-4.2%-10.3%
5Y-4.2%10Y-0.6%-3.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Shenzhen Neptunus Bioengineering Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Shenzhen Neptunus Bioengineering Co Ltd is operating .

  • Measures how much profit Shenzhen Neptunus Bioengineering Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.3%-0.3%
TTM0.3%YOY-2.5%+2.8%
TTM0.3%5Y0.6%-0.3%
5Y0.6%10Y2.3%-1.7%
4.3.2.2. Operating Ratio

Measures how efficient Shenzhen Neptunus Bioengineering Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.88 means that the operating costs are ¥1.88 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 1.879. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.430. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.879TTM1.430+0.450
TTM1.430YOY0.971+0.459
TTM1.4305Y1.056+0.374
5Y1.05610Y1.001+0.054
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Shenzhen Neptunus Bioengineering Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Shenzhen Neptunus Bioengineering Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.04 means the company has ¥1.04 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 1.043. The company is just able to pay all its short-term debts.
  • The TTM is 1.041. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.043TTM1.041+0.003
TTM1.041YOY1.064-0.023
TTM1.0415Y1.061-0.020
5Y1.06110Y1.115-0.054
4.4.3.2. Quick Ratio

Measures if Shenzhen Neptunus Bioengineering Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.64 means the company can pay off ¥0.64 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.637. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.723. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.637TTM0.723-0.086
TTM0.723YOY0.921-0.199
TTM0.7235Y0.894-0.171
5Y0.89410Y0.948-0.054
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Shenzhen Neptunus Bioengineering Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Shenzhen Neptunus Bioengineering Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.87 means that Shenzhen Neptunus Bioengineering Co Ltd assets are financed with 86.6% credit (debt) and the remaining percentage (100% - 86.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 0.866. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.868. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.866TTM0.868-0.002
TTM0.868YOY0.831+0.037
TTM0.8685Y0.824+0.044
5Y0.82410Y0.798+0.026
4.5.4.2. Debt to Equity Ratio

Measures if Shenzhen Neptunus Bioengineering Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 893.6% means that company has ¥8.94 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The MRQ is 8.936. The company is unable to pay all its debts with equity. -1
  • The TTM is 9.161. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ8.936TTM9.161-0.225
TTM9.161YOY6.361+2.800
TTM9.1615Y6.271+2.889
5Y6.27110Y5.349+0.923
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shenzhen Neptunus Bioengineering Co Ltd generates.

  • Above 15 is considered overpriced but always compare Shenzhen Neptunus Bioengineering Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 2,134.24 means the investor is paying ¥2,134.24 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The EOD is 1,995.756. Based on the earnings, the company is expensive. -2
  • The MRQ is 2,134.237. Based on the earnings, the company is expensive. -2
  • The TTM is 674.303. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1,995.756MRQ2,134.237-138.481
MRQ2,134.237TTM674.303+1,459.934
TTM674.303YOY706.533-32.230
TTM674.3035Y296.200+378.102
5Y296.20010Y181.394+114.806
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The EOD is -18.049. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.301. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 23.380. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-18.049MRQ-19.301+1.252
MRQ-19.301TTM23.380-42.682
TTM23.380YOY4.762+18.619
TTM23.3805Y-31.974+55.354
5Y-31.97410Y-23.149-8.824
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Shenzhen Neptunus Bioengineering Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shenzhen Neptunus Bioengineering Co Ltd:

  • The EOD is 1.538. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.645. Based on the equity, the company is underpriced. +1
  • The TTM is 1.620. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.538MRQ1.645-0.107
MRQ1.645TTM1.620+0.025
TTM1.620YOY1.386+0.233
TTM1.6205Y1.391+0.229
5Y1.39110Y4.614-3.223
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets31,318,856
Total Liabilities27,128,365
Total Stockholder Equity3,035,898
 As reported
Total Liabilities 27,128,365
Total Stockholder Equity+ 3,035,898
Total Assets = 31,318,856

Assets

Total Assets31,318,856
Total Current Assets27,847,481
Long-term Assets3,471,375
Total Current Assets
Cash And Cash Equivalents 3,259,218
Short-term Investments 128,217
Net Receivables 16,868,213
Inventory 3,592,263
Other Current Assets 277,325
Total Current Assets  (as reported)27,847,481
Total Current Assets  (calculated)24,125,235
+/- 3,722,246
Long-term Assets
Property Plant Equipment 1,288,257
Goodwill 856,486
Intangible Assets 471,198
Long-term Assets Other 120,399
Long-term Assets  (as reported)3,471,375
Long-term Assets  (calculated)2,736,339
+/- 735,035

Liabilities & Shareholders' Equity

Total Current Liabilities26,691,471
Long-term Liabilities436,894
Total Stockholder Equity3,035,898
Total Current Liabilities
Short Long Term Debt 10,472,660
Accounts payable 9,778,077
Other Current Liabilities 415,153
Total Current Liabilities  (as reported)26,691,471
Total Current Liabilities  (calculated)20,665,890
+/- 6,025,581
Long-term Liabilities
Long term Debt 269,449
Capital Lease Obligations Min Short Term Debt136,076
Long-term Liabilities  (as reported)436,894
Long-term Liabilities  (calculated)405,525
+/- 31,369
Total Stockholder Equity
Total Stockholder Equity (as reported)3,035,898
Total Stockholder Equity (calculated)0
+/- 3,035,898
Other
Capital Stock2,631,123
Common Stock Shares Outstanding 2,631,123
Net Debt 7,482,892
Net Invested Capital 13,778,008
Net Working Capital 1,156,010
Property Plant and Equipment Gross 1,288,257



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-301999-12-311999-06-301998-12-311998-06-30
> Total Assets 
151,665
229,965
249,477
642,281
710,017
872,297
3,087,390
3,043,627
3,138,470
3,118,497
3,170,397
3,429,312
4,211,749
4,453,714
4,492,627
4,029,470
4,193,376
4,173,862
3,854,133
3,727,844
3,835,984
3,996,479
4,311,598
3,986,122
4,150,103
3,694,895
3,583,355
3,522,390
3,441,517
3,078,071
3,069,585
3,121,599
3,034,145
2,943,602
2,950,175
2,777,538
3,000,302
3,039,329
3,068,806
3,164,753
3,521,914
3,691,678
3,865,663
4,147,789
4,353,551
4,527,135
4,697,059
4,835,322
5,078,776
5,358,497
5,582,141
5,863,516
6,976,273
6,419,183
6,970,608
8,019,242
8,334,910
8,977,044
9,352,063
9,631,707
10,944,882
11,415,116
12,163,686
12,762,259
13,513,609
14,826,612
14,708,244
16,661,466
17,474,257
21,605,144
25,275,313
30,864,383
33,631,869
35,426,770
35,716,143
41,126,743
39,273,306
41,859,463
39,772,678
41,168,284
43,683,253
40,088,867
40,323,819
39,720,507
41,998,396
40,113,330
39,827,939
37,603,849
36,942,030
36,629,960
36,745,760
36,252,276
36,728,074
36,414,629
36,011,587
32,304,687
32,662,246
31,759,675
31,318,856
31,318,85631,759,67532,662,24632,304,68736,011,58736,414,62936,728,07436,252,27636,745,76036,629,96036,942,03037,603,84939,827,93940,113,33041,998,39639,720,50740,323,81940,088,86743,683,25341,168,28439,772,67841,859,46339,273,30641,126,74335,716,14335,426,77033,631,86930,864,38325,275,31321,605,14417,474,25716,661,46614,708,24414,826,61213,513,60912,762,25912,163,68611,415,11610,944,8829,631,7079,352,0638,977,0448,334,9108,019,2426,970,6086,419,1836,976,2735,863,5165,582,1415,358,4975,078,7764,835,3224,697,0594,527,1354,353,5514,147,7893,865,6633,691,6783,521,9143,164,7533,068,8063,039,3293,000,3022,777,5382,950,1752,943,6023,034,1453,121,5993,069,5853,078,0713,441,5173,522,3903,583,3553,694,8954,150,1033,986,1224,311,5983,996,4793,835,9843,727,8443,854,1334,173,8624,193,3764,029,4704,492,6274,453,7144,211,7493,429,3123,170,3973,118,4973,138,4703,043,6273,087,390872,297710,017642,281249,477229,965151,665
   > Total Current Assets 
69,548
144,591
101,531
205,133
281,671
399,379
2,380,759
2,070,012
2,111,530
2,071,159
2,147,370
2,357,384
3,023,841
3,270,342
3,219,969
2,830,142
3,026,178
2,951,419
2,630,615
2,778,064
2,818,757
2,995,804
3,227,693
2,946,227
0
2,589,751
2,468,628
2,404,831
2,319,280
1,966,132
1,966,137
2,142,904
2,090,262
1,967,793
1,980,205
1,792,502
1,957,757
1,911,306
1,854,796
1,915,204
2,201,587
2,427,538
2,615,604
2,957,953
3,170,676
3,329,874
3,487,794
3,866,810
4,082,512
4,328,396
4,530,383
4,728,292
5,814,577
5,255,534
5,716,884
6,626,069
6,981,092
7,583,456
7,873,107
7,934,128
9,219,882
9,639,487
10,995,790
11,174,069
12,013,891
13,316,803
12,956,079
14,314,426
14,918,943
17,712,968
20,435,090
25,002,743
27,408,020
29,166,136
29,188,451
33,604,503
31,517,868
34,428,198
32,351,719
34,569,577
37,121,507
33,547,681
33,868,301
33,629,751
35,744,678
33,577,005
33,227,276
31,616,610
30,961,293
30,756,956
30,877,442
31,524,549
32,051,719
31,755,592
31,420,784
28,809,401
29,072,115
28,252,922
27,847,481
27,847,48128,252,92229,072,11528,809,40131,420,78431,755,59232,051,71931,524,54930,877,44230,756,95630,961,29331,616,61033,227,27633,577,00535,744,67833,629,75133,868,30133,547,68137,121,50734,569,57732,351,71934,428,19831,517,86833,604,50329,188,45129,166,13627,408,02025,002,74320,435,09017,712,96814,918,94314,314,42612,956,07913,316,80312,013,89111,174,06910,995,7909,639,4879,219,8827,934,1287,873,1077,583,4566,981,0926,626,0695,716,8845,255,5345,814,5774,728,2924,530,3834,328,3964,082,5123,866,8103,487,7943,329,8743,170,6762,957,9532,615,6042,427,5382,201,5871,915,2041,854,7961,911,3061,957,7571,792,5021,980,2051,967,7932,090,2622,142,9041,966,1371,966,1322,319,2802,404,8312,468,6282,589,75102,946,2273,227,6932,995,8042,818,7572,778,0642,630,6152,951,4193,026,1782,830,1423,219,9693,270,3423,023,8412,357,3842,147,3702,071,1592,111,5302,070,0122,380,759399,379281,671205,133101,531144,59169,548
       Cash And Cash Equivalents 
4,647
55,287
20,463
38,145
73,309
102,518
1,126,745
1,194,599
0
1,120,297
980,393
1,193,462
1,547,657
1,595,369
1,398,593
1,414,928
1,261,059
1,106,310
680,180
726,770
622,617
801,118
861,241
1,116,656
0
948,763
844,770
705,242
702,124
523,324
498,322
506,872
402,934
442,647
432,120
392,613
450,603
537,010
415,085
467,828
597,830
632,009
670,465
901,693
832,829
823,528
624,179
817,077
831,728
977,887
1,006,682
1,085,252
1,661,689
1,092,276
1,014,897
1,496,651
1,456,740
1,631,379
1,578,381
1,530,338
1,801,697
1,934,579
2,233,369
3,075,829
3,340,578
4,099,758
2,677,572
3,072,500
2,047,627
3,013,531
3,204,714
3,211,936
3,710,892
3,231,033
3,334,940
4,089,094
3,556,813
5,496,283
5,198,663
6,098,286
7,881,287
6,837,038
6,411,136
5,367,554
5,365,508
4,461,437
4,108,279
4,127,017
3,742,342
3,535,869
3,119,076
3,100,839
3,335,348
3,211,279
3,034,211
3,480,401
3,769,211
3,995,252
3,259,218
3,259,2183,995,2523,769,2113,480,4013,034,2113,211,2793,335,3483,100,8393,119,0763,535,8693,742,3424,127,0174,108,2794,461,4375,365,5085,367,5546,411,1366,837,0387,881,2876,098,2865,198,6635,496,2833,556,8134,089,0943,334,9403,231,0333,710,8923,211,9363,204,7143,013,5312,047,6273,072,5002,677,5724,099,7583,340,5783,075,8292,233,3691,934,5791,801,6971,530,3381,578,3811,631,3791,456,7401,496,6511,014,8971,092,2761,661,6891,085,2521,006,682977,887831,728817,077624,179823,528832,829901,693670,465632,009597,830467,828415,085537,010450,603392,613432,120442,647402,934506,872498,322523,324702,124705,242844,770948,76301,116,656861,241801,118622,617726,770680,1801,106,3101,261,0591,414,9281,398,5931,595,3691,547,6571,193,462980,3931,120,29701,194,5991,126,745102,51873,30938,14520,46355,2874,647
       Short-term Investments 
0
0
0
0
0
0
62,155
33,872
0
7,198
29,515
22,998
19,926
28,036
26,003
19,718
37,030
5,150
6,868
295,348
289,608
239,570
251,875
148,162
0
96
91
100
107
100
100
122
122
115
117
122
123
123
121
125
129
130
130
134
133
132
130
133
135
138
139
141
140
3,140
139
-252,812
-202,070
-249,231
-246,294
-353,986
-354,050
-352,751
-272,727
-259,316
-257,509
-263,576
-261,636
-256,946
-257,846
-326,542
-342,653
-367,857
-339,328
-380,898
-391,058
-393,947
-390,374
-385,462
-381,300
13,160
17,920
-275,598
-289,470
239,485
207,157
238,296
237,702
35,207
39,892
120,018
105,000
217,714
199,545
168,738
150,615
194,413
162,970
130,283
128,217
128,217130,283162,970194,413150,615168,738199,545217,714105,000120,01839,89235,207237,702238,296207,157239,485-289,470-275,59817,92013,160-381,300-385,462-390,374-393,947-391,058-380,898-339,328-367,857-342,653-326,542-257,846-256,946-261,636-263,576-257,509-259,316-272,727-352,751-354,050-353,986-246,294-249,231-202,070-252,8121393,14014014113913813513313013213313413013012912512112312312211711512212210010010710091960148,162251,875239,570289,608295,3486,8685,15037,03019,71826,00328,03619,92622,99829,5157,198033,87262,155000000
       Net Receivables 
2,014
1,909
924
4,694
4,453
2,179
200,876
783,167
0
875,096
1,055,905
1,074,715
1,277,537
1,449,942
1,545,743
1,321,172
1,920,623
2,059,168
2,226,060
1,755,674
1,599,693
2,127,833
2,194,592
1,644,929
1,051,823
1,584,066
1,542,004
1,858,988
1,310,216
1,150,609
1,190,227
1,969,787
1,438,372
1,276,270
1,291,377
1,155,569
1,238,479
1,490,645
1,161,808
1,381,556
1,226,753
1,412,097
1,552,984
1,939,361
1,866,396
2,352,084
2,680,291
2,733,283
2,973,504
3,046,101
3,176,793
2,937,320
3,980,404
3,428,647
3,904,440
4,268,271
4,628,907
5,035,046
5,363,021
5,347,104
6,283,147
6,562,285
7,599,834
6,930,672
7,586,911
8,003,000
8,931,458
9,708,224
11,235,500
12,299,188
14,250,594
18,314,896
19,904,098
22,016,321
21,779,329
24,668,257
23,175,915
24,580,904
22,845,500
24,487,001
24,955,536
22,819,736
23,637,180
23,872,317
26,094,140
25,014,102
25,031,771
23,424,097
23,477,030
23,336,783
23,616,317
23,427,244
23,941,159
24,058,358
24,194,440
18,631,993
18,815,811
16,773,208
16,868,213
16,868,21316,773,20818,815,81118,631,99324,194,44024,058,35823,941,15923,427,24423,616,31723,336,78323,477,03023,424,09725,031,77125,014,10226,094,14023,872,31723,637,18022,819,73624,955,53624,487,00122,845,50024,580,90423,175,91524,668,25721,779,32922,016,32119,904,09818,314,89614,250,59412,299,18811,235,5009,708,2248,931,4588,003,0007,586,9116,930,6727,599,8346,562,2856,283,1475,347,1045,363,0215,035,0464,628,9074,268,2713,904,4403,428,6473,980,4042,937,3203,176,7933,046,1012,973,5042,733,2832,680,2912,352,0841,866,3961,939,3611,552,9841,412,0971,226,7531,381,5561,161,8081,490,6451,238,4791,155,5691,291,3771,276,2701,438,3721,969,7871,190,2271,150,6091,310,2161,858,9881,542,0041,584,0661,051,8231,644,9292,194,5922,127,8331,599,6931,755,6742,226,0602,059,1681,920,6231,321,1721,545,7431,449,9421,277,5371,074,7151,055,905875,0960783,167200,8762,1794,4534,6949241,9092,014
       Inventory 
7,912
6,441
9,494
22,236
22,314
24,961
134,949
58,373
0
68,364
81,351
66,087
178,535
195,794
248,075
240,999
274,267
277,029
275,541
311,970
306,838
291,806
333,035
324,696
356,029
286,465
285,604
318,481
306,412
292,068
276,978
246,801
248,322
248,371
256,201
242,181
266,913
269,801
277,413
333,192
376,789
382,929
391,704
494,176
467,092
511,062
528,594
661,185
554,830
591,952
645,564
704,933
716,127
731,157
796,383
857,619
867,465
890,916
915,240
1,002,221
1,058,480
1,095,613
1,115,486
1,065,941
1,038,706
1,181,653
1,321,453
1,484,955
1,562,100
2,296,611
2,918,508
3,328,700
3,626,133
3,715,816
3,816,065
3,950,969
4,154,424
3,728,169
3,700,483
3,723,455
4,038,199
3,686,432
3,641,002
3,905,350
3,857,487
3,675,780
3,620,535
3,792,908
3,521,681
3,366,008
3,643,521
4,193,040
4,059,004
3,697,134
3,471,717
3,679,480
3,465,042
3,498,242
3,592,263
3,592,2633,498,2423,465,0423,679,4803,471,7173,697,1344,059,0044,193,0403,643,5213,366,0083,521,6813,792,9083,620,5353,675,7803,857,4873,905,3503,641,0023,686,4324,038,1993,723,4553,700,4833,728,1694,154,4243,950,9693,816,0653,715,8163,626,1333,328,7002,918,5082,296,6111,562,1001,484,9551,321,4531,181,6531,038,7061,065,9411,115,4861,095,6131,058,4801,002,221915,240890,916867,465857,619796,383731,157716,127704,933645,564591,952554,830661,185528,594511,062467,092494,176391,704382,929376,789333,192277,413269,801266,913242,181256,201248,371248,322246,801276,978292,068306,412318,481285,604286,465356,029324,696333,035291,806306,838311,970275,541277,029274,267240,999248,075195,794178,53566,08781,35168,364058,373134,94924,96122,31422,2369,4946,4417,912
       Other Current Assets 
54,975
80,955
70,650
140,057
181,595
269,720
856,034
0
2,111,530
204
206
123
186
1,202
1,555
-166,676
-466,800
-496,238
-558,034
-311,698
2
-464,523
-413,050
-288,215
532,531
-229,638
-203,841
-477,980
421
31
510
-580,678
512
390
390
2,017
1,641
-386,273
369
-267,497
86
372
321
-377,412
4,227
-356,932
-345,400
-344,868
-277,684
-287,682
-298,795
645
-543,782
314
1,024
3,529
27,979
26,116
16,464
54,465
76,558
47,011
47,102
101,627
47,697
32,392
25,596
48,747
73,716
103,639
61,273
147,211
166,896
202,966
258,116
896,183
630,717
622,842
607,073
247,676
228,566
204,474
178,983
245,045
220,385
187,389
228,989
237,381
180,348
398,277
393,528
585,712
516,664
620,084
569,802
442,406
409,977
338,683
277,325
277,325338,683409,977442,406569,802620,084516,664585,712393,528398,277180,348237,381228,989187,389220,385245,045178,983204,474228,566247,676607,073622,842630,717896,183258,116202,966166,896147,21161,273103,63973,71648,74725,59632,39247,697101,62747,10247,01176,55854,46516,46426,11627,9793,5291,024314-543,782645-298,795-287,682-277,684-344,868-345,400-356,9324,227-377,41232137286-267,497369-386,2731,6412,017390390512-580,67851031421-477,980-203,841-229,638532,531-288,215-413,050-464,5232-311,698-558,034-496,238-466,800-166,6761,5551,2021861232062042,111,5300856,034269,720181,595140,05770,65080,95554,975
   > Long-term Assets 
82,117
85,374
147,946
437,149
428,346
472,919
706,631
973,615
1,026,940
1,047,338
1,023,028
1,071,928
1,187,908
1,183,372
1,272,658
1,199,329
1,167,197
1,222,443
1,223,518
949,780
1,017,227
1,000,674
1,083,905
1,039,895
4,150,103
1,105,144
1,114,727
1,117,559
1,122,237
1,111,939
1,103,448
978,695
943,884
975,808
969,971
985,036
1,042,545
1,128,023
1,214,009
1,249,549
1,320,327
1,264,140
1,250,059
1,189,836
1,182,874
1,197,261
1,209,265
968,512
996,264
1,030,101
1,051,758
1,135,225
1,161,696
1,163,649
1,253,724
1,393,173
1,353,818
1,393,588
1,478,956
1,697,579
1,725,001
1,775,628
1,167,895
1,588,190
1,499,718
1,509,810
1,752,165
2,347,041
2,555,314
3,892,176
4,840,223
5,861,639
6,223,849
6,260,634
6,527,692
7,522,241
7,755,438
7,431,265
7,420,959
6,598,707
6,561,746
6,541,186
6,455,518
6,090,756
6,253,718
6,536,325
6,600,663
5,987,239
5,980,737
5,873,005
5,868,318
4,727,727
4,676,354
4,659,037
4,590,803
3,495,286
3,590,131
3,506,754
3,471,375
3,471,3753,506,7543,590,1313,495,2864,590,8034,659,0374,676,3544,727,7275,868,3185,873,0055,980,7375,987,2396,600,6636,536,3256,253,7186,090,7566,455,5186,541,1866,561,7466,598,7077,420,9597,431,2657,755,4387,522,2416,527,6926,260,6346,223,8495,861,6394,840,2233,892,1762,555,3142,347,0411,752,1651,509,8101,499,7181,588,1901,167,8951,775,6281,725,0011,697,5791,478,9561,393,5881,353,8181,393,1731,253,7241,163,6491,161,6961,135,2251,051,7581,030,101996,264968,5121,209,2651,197,2611,182,8741,189,8361,250,0591,264,1401,320,3271,249,5491,214,0091,128,0231,042,545985,036969,971975,808943,884978,6951,103,4481,111,9391,122,2371,117,5591,114,7271,105,1444,150,1031,039,8951,083,9051,000,6741,017,227949,7801,223,5181,222,4431,167,1971,199,3291,272,6581,183,3721,187,9081,071,9281,023,0281,047,3381,026,940973,615706,631472,919428,346437,149147,94685,37482,117
       Property Plant Equipment 
36,351
39,579
44,016
213,639
215,238
232,370
278,918
366,296
0
411,252
356,494
403,536
446,454
453,695
515,087
13,692
402,199
431,409
443,944
607,685
637,028
660,798
699,304
720,704
0
763,190
756,907
767,742
761,755
794,613
793,863
649,467
665,727
690,136
695,602
687,762
690,792
705,737
743,450
454,423
449,917
422,367
417,783
420,052
418,749
432,380
448,496
447,494
453,583
484,055
507,457
565,555
588,857
596,832
630,958
625,571
678,603
653,199
714,157
795,093
825,813
832,072
434,590
508,617
445,922
482,963
530,676
580,362
616,790
675,492
735,629
889,790
925,112
998,260
1,031,298
1,020,591
1,013,626
1,059,716
1,066,039
1,082,223
1,066,474
1,039,803
1,046,003
1,169,700
1,422,620
1,510,560
1,501,995
1,465,769
1,439,265
1,406,912
1,420,365
1,374,599
1,342,861
1,314,468
1,273,555
1,276,292
1,307,983
1,260,351
1,288,257
1,288,2571,260,3511,307,9831,276,2921,273,5551,314,4681,342,8611,374,5991,420,3651,406,9121,439,2651,465,7691,501,9951,510,5601,422,6201,169,7001,046,0031,039,8031,066,4741,082,2231,066,0391,059,7161,013,6261,020,5911,031,298998,260925,112889,790735,629675,492616,790580,362530,676482,963445,922508,617434,590832,072825,813795,093714,157653,199678,603625,571630,958596,832588,857565,555507,457484,055453,583447,494448,496432,380418,749420,052417,783422,367449,917454,423743,450705,737690,792687,762695,602690,136665,727649,467793,863794,613761,755767,742756,907763,1900720,704699,304660,798637,028607,685443,944431,409402,19913,692515,087453,695446,454403,536356,494411,2520366,296278,918232,370215,238213,63944,01639,57936,351
       Goodwill 
0
0
0
0
0
0
125,419
0
0
0
0
0
0
0
0
13,791
0
0
0
12,300
0
11,554
0
10,809
0
0
0
9,318
0
32,469
23,897
24,684
24,684
24,684
24,684
24,684
24,684
24,684
24,684
25,444
25,444
31,782
31,782
29,273
31,325
31,325
31,325
31,021
31,021
31,021
31,021
31,021
31,021
31,021
39,021
39,021
39,021
39,021
39,021
39,521
45,521
45,521
45,521
102,645
102,645
104,645
157,800
476,775
568,049
1,828,605
2,516,681
3,549,464
3,690,668
3,775,586
3,936,651
3,917,842
3,980,535
3,888,479
3,840,047
3,331,150
3,331,150
3,296,850
3,076,030
2,472,630
2,472,630
2,562,793
2,562,793
2,328,605
2,328,605
2,328,605
2,319,005
1,745,538
1,745,538
1,745,538
1,745,538
863,286
863,286
856,486
856,486
856,486856,486863,286863,2861,745,5381,745,5381,745,5381,745,5382,319,0052,328,6052,328,6052,328,6052,562,7932,562,7932,472,6302,472,6303,076,0303,296,8503,331,1503,331,1503,840,0473,888,4793,980,5353,917,8423,936,6513,775,5863,690,6683,549,4642,516,6811,828,605568,049476,775157,800104,645102,645102,64545,52145,52145,52139,52139,02139,02139,02139,02139,02131,02131,02131,02131,02131,02131,02131,02131,32531,32531,32529,27331,78231,78225,44425,44424,68424,68424,68424,68424,68424,68424,68424,68423,89732,46909,31800010,809011,554012,30000013,79100000000125,419000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
503,509
596,614
468,590
468,590
454,882
466,396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000466,396454,882468,590468,590596,614503,5090000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
15,233
14,945
61,428
182,463
173,440
165,978
-101,905
84,055
0
160,047
214,740
209,137
261,501
259,771
308,631
119,977
130,850
139,654
148,006
148,291
157,750
145,205
154,713
134,779
0
141,999
153,285
139,199
177,223
149,251
156,393
154,792
153,133
163,913
150,499
150,166
202,171
229,367
249,319
173,872
174,239
166,124
166,539
187,672
186,530
196,406
199,891
209,761
228,661
229,284
230,945
244,486
249,432
250,361
254,901
309,154
313,513
316,568
327,320
314,826
319,003
337,582
281,187
332,609
316,466
344,950
343,916
366,287
389,795
398,296
411,808
399,284
422,433
323,209
330,197
345,367
349,584
354,593
363,981
396,496
403,070
398,469
399,558
400,576
400,432
450,441
501,168
532,348
530,204
535,859
528,225
518,446
515,168
509,608
506,223
472,133
467,007
472,994
471,198
471,198472,994467,007472,133506,223509,608515,168518,446528,225535,859530,204532,348501,168450,441400,432400,576399,558398,469403,070396,496363,981354,593349,584345,367330,197323,209422,433399,284411,808398,296389,795366,287343,916344,950316,466332,609281,187337,582319,003314,826327,320316,568313,513309,154254,901250,361249,432244,486230,945229,284228,661209,761199,891196,406186,530187,672166,539166,124174,239173,872249,319229,367202,171150,166150,499163,913153,133154,792156,393149,251177,223139,199153,285141,9990134,779154,713145,205157,750148,291148,006139,654130,850119,977308,631259,771261,501209,137214,740160,047084,055-101,905165,978173,440182,46361,42814,94515,233
       Long-term Assets Other 
30,533
30,851
42,503
41,047
39,668
74,571
5,000
20,000
1,026,940
20,000
13,000
20,000
20,000
20,000
20,000
443,479
625,776
12,600
14,512
303,589
59
247,037
259,323
152,042
4,150,103
2,280
2,102
1,551
1,412
1,329
1,209
31,539
31,222
23,558
24,757
42,558
41,815
89,031
108,027
144,738
204,188
202,511
200,803
195,016
195,156
187,728
187,913
189,152
189,080
190,890
187,314
186,596
180,058
172,835
168,078
22,814
15,699
40,966
53,739
80,430
62,999
55,436
35,200
262,900
249,322
178,745
305,349
333,667
394,776
135,816
303,577
99,727
272,110
145,601
99,416
1,127,056
1,305,337
1,023,204
1,034,713
926,903
890,938
601,858
705,002
1,357,467
1,224,602
1,303,715
1,321,768
969,834
793,294
815,275
800,354
508,296
476,126
459,285
419,663
212,867
282,111
146,680
120,399
120,399146,680282,111212,867419,663459,285476,126508,296800,354815,275793,294969,8341,321,7681,303,7151,224,6021,357,467705,002601,858890,938926,9031,034,7131,023,2041,305,3371,127,05699,416145,601272,11099,727303,577135,816394,776333,667305,349178,745249,322262,90035,20055,43662,99980,43053,73940,96615,69922,814168,078172,835180,058186,596187,314190,890189,080189,152187,913187,728195,156195,016200,803202,511204,188144,738108,02789,03141,81542,55824,75723,55831,22231,5391,2091,3291,4121,5512,1022,2804,150,103152,042259,323247,03759303,58914,51212,600625,776443,47920,00020,00020,00020,00013,00020,0001,026,94020,0005,00074,57139,66841,04742,50330,85130,533
> Total Liabilities 
79,781
52,889
45,486
436,592
475,914
633,549
1,162,357
1,068,857
3,138,470
1,071,369
1,112,920
1,366,118
2,142,024
2,360,186
2,411,237
2,586,057
2,412,194
2,367,455
2,040,276
2,275,880
2,154,284
2,383,663
2,609,430
3,180,865
4,150,103
2,871,569
2,755,025
2,653,631
2,580,438
2,201,854
2,177,440
2,217,976
2,151,013
2,043,218
2,056,541
1,996,751
2,217,911
2,270,401
2,314,798
2,472,167
2,808,556
2,956,246
3,121,206
3,245,166
3,411,223
3,555,137
3,716,511
3,864,282
4,067,905
4,313,805
4,516,351
4,806,539
5,288,225
4,687,214
5,219,165
6,131,235
6,590,551
7,190,174
7,551,674
7,849,130
9,103,041
9,352,936
9,992,706
10,619,197
11,286,592
9,538,761
9,250,848
10,783,505
11,443,298
15,428,931
18,890,572
24,394,385
26,932,244
28,458,277
28,556,279
33,968,398
31,415,193
34,117,796
31,810,873
33,317,581
35,715,479
32,026,043
32,182,969
32,230,711
34,365,496
32,743,138
32,326,008
30,295,591
29,549,173
29,222,131
29,347,901
30,141,845
30,562,049
30,239,980
29,825,393
28,087,241
28,406,589
27,510,023
27,128,365
27,128,36527,510,02328,406,58928,087,24129,825,39330,239,98030,562,04930,141,84529,347,90129,222,13129,549,17330,295,59132,326,00832,743,13834,365,49632,230,71132,182,96932,026,04335,715,47933,317,58131,810,87334,117,79631,415,19333,968,39828,556,27928,458,27726,932,24424,394,38518,890,57215,428,93111,443,29810,783,5059,250,8489,538,76111,286,59210,619,1979,992,7069,352,9369,103,0417,849,1307,551,6747,190,1746,590,5516,131,2355,219,1654,687,2145,288,2254,806,5394,516,3514,313,8054,067,9053,864,2823,716,5113,555,1373,411,2233,245,1663,121,2062,956,2462,808,5562,472,1672,314,7982,270,4012,217,9111,996,7512,056,5412,043,2182,151,0132,217,9762,177,4402,201,8542,580,4382,653,6312,755,0252,871,5694,150,1033,180,8652,609,4302,383,6632,154,2842,275,8802,040,2762,367,4552,412,1942,586,0572,411,2372,360,1862,142,0241,366,1181,112,9201,071,3693,138,4701,068,8571,162,357633,549475,914436,59245,48652,88979,781
   > Total Current Liabilities 
76,859
50,479
42,244
433,502
473,466
631,549
1,156,757
1,068,857
1,122,290
1,071,269
1,112,820
1,347,191
2,124,738
2,343,910
2,389,398
2,579,057
2,405,194
2,360,455
2,033,276
2,272,880
2,146,284
2,380,663
2,605,430
3,179,865
3,309,776
2,740,569
2,624,025
2,525,631
2,413,807
2,062,193
2,052,440
2,092,632
2,029,213
1,928,418
1,941,741
1,791,931
2,020,591
2,090,581
2,142,478
2,345,461
2,683,449
2,840,868
3,004,919
3,180,636
3,346,447
3,553,157
3,716,344
3,855,781
4,062,405
4,308,302
4,510,852
4,801,499
5,286,178
4,684,305
5,216,248
6,116,926
6,577,204
7,177,560
7,544,161
7,779,722
9,033,271
9,285,500
9,972,645
10,433,956
11,100,791
9,347,648
9,062,243
10,618,696
11,283,474
14,530,180
17,148,627
22,653,118
24,132,278
25,693,707
24,060,330
30,546,689
27,497,396
30,686,575
28,428,478
31,827,202
34,050,194
31,317,735
31,477,220
31,871,459
33,807,010
32,177,299
31,686,208
29,761,680
29,000,991
28,626,523
28,781,690
29,693,943
30,163,464
29,841,278
29,451,084
27,728,358
28,013,922
27,091,460
26,691,471
26,691,47127,091,46028,013,92227,728,35829,451,08429,841,27830,163,46429,693,94328,781,69028,626,52329,000,99129,761,68031,686,20832,177,29933,807,01031,871,45931,477,22031,317,73534,050,19431,827,20228,428,47830,686,57527,497,39630,546,68924,060,33025,693,70724,132,27822,653,11817,148,62714,530,18011,283,47410,618,6969,062,2439,347,64811,100,79110,433,9569,972,6459,285,5009,033,2717,779,7227,544,1617,177,5606,577,2046,116,9265,216,2484,684,3055,286,1784,801,4994,510,8524,308,3024,062,4053,855,7813,716,3443,553,1573,346,4473,180,6363,004,9192,840,8682,683,4492,345,4612,142,4782,090,5812,020,5911,791,9311,941,7411,928,4182,029,2132,092,6322,052,4402,062,1932,413,8072,525,6312,624,0252,740,5693,309,7763,179,8652,605,4302,380,6632,146,2842,272,8802,033,2762,360,4552,405,1942,579,0572,389,3982,343,9102,124,7381,347,1911,112,8201,071,2691,122,2901,068,8571,156,757631,549473,466433,50242,24450,47976,859
       Short-term Debt 
23,000
30,000
30,000
254,435
424,075
557,546
1,054,245
898,000
0
943,863
812,903
803,300
933,445
1,087,065
1,162,235
1,094,520
1,104,520
1,063,170
1,108,570
1,192,370
1,179,320
1,202,720
1,191,420
1,289,370
0
1,043,370
1,020,170
925,010
948,994
961,235
939,900
909,850
932,827
827,535
820,480
717,660
758,941
804,898
975,600
1,021,600
1,219,100
1,359,400
1,409,110
1,531,073
1,466,573
1,665,938
1,695,797
1,648,129
1,782,745
1,967,184
1,981,954
2,269,083
2,477,338
2,072,501
1,951,660
2,390,460
2,431,859
2,371,969
2,808,083
2,800,883
3,407,593
3,326,298
3,094,925
2,763,010
2,858,540
1,552,010
1,169,085
2,243,390
3,431,160
4,572,492
4,212,935
4,344,931
4,844,941
5,487,241
5,646,949
9,694,424
7,182,352
8,557,769
8,643,124
11,644,375
12,937,717
11,285,435
11,601,202
14,148,072
13,542,895
13,303,336
12,783,390
12,198,863
11,479,450
11,235,677
11,317,582
11,615,508
12,192,863
12,114,070
12,001,800
11,077,988
11,038,076
0
0
0011,038,07611,077,98812,001,80012,114,07012,192,86311,615,50811,317,58211,235,67711,479,45012,198,86312,783,39013,303,33613,542,89514,148,07211,601,20211,285,43512,937,71711,644,3758,643,1248,557,7697,182,3529,694,4245,646,9495,487,2414,844,9414,344,9314,212,9354,572,4923,431,1602,243,3901,169,0851,552,0102,858,5402,763,0103,094,9253,326,2983,407,5932,800,8832,808,0832,371,9692,431,8592,390,4601,951,6602,072,5012,477,3382,269,0831,981,9541,967,1841,782,7451,648,1291,695,7971,665,9381,466,5731,531,0731,409,1101,359,4001,219,1001,021,600975,600804,898758,941717,660820,480827,535932,827909,850939,900961,235948,994925,0101,020,1701,043,37001,289,3701,191,4201,202,7201,179,3201,192,3701,108,5701,063,1701,104,5201,094,5201,162,2351,087,065933,445803,300812,903943,8630898,0001,054,245557,546424,075254,43530,00030,00023,000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
945,107
6,036,024
8,134,968
8,643,124
9,831,203
11,157,455
10,019,586
11,589,202
14,091,522
13,518,895
13,278,436
12,759,390
11,924,827
11,190,347
11,033,247
11,140,570
11,410,259
11,979,238
11,880,752
11,770,026
10,832,202
10,778,486
10,444,657
10,472,660
10,472,66010,444,65710,778,48610,832,20211,770,02611,880,75211,979,23811,410,25911,140,57011,033,24711,190,34711,924,82712,759,39013,278,43613,518,89514,091,52211,589,20210,019,58611,157,4559,831,2038,643,1248,134,9686,036,024945,107000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
13,433
2,443
2,222
9,564
10,100
11,163
32,739
93,308
0
44,825
235,281
380,669
1,017,096
998,745
1,072,940
1,119,600
1,178,840
1,163,245
758,191
756,392
846,912
987,834
1,232,288
1,589,314
541,109
1,433,599
1,341,457
1,322,026
1,225,620
874,100
950,926
1,054,003
950,761
866,750
884,655
752,781
920,122
992,076
917,971
1,041,152
1,185,198
1,225,951
1,300,634
1,357,875
1,504,891
1,525,801
1,772,617
1,835,422
1,960,693
2,082,246
2,268,792
2,102,173
2,259,864
2,439,363
2,721,566
3,073,402
3,589,082
4,049,031
3,913,656
4,010,822
4,662,146
4,845,672
5,732,743
6,344,403
6,963,598
6,666,010
6,840,634
6,796,587
6,634,496
6,548,032
7,380,801
9,393,400
10,609,198
11,034,397
9,616,867
10,802,277
11,957,221
12,126,711
11,581,223
12,028,674
13,254,143
12,698,430
12,085,066
10,727,648
12,505,995
10,898,571
11,057,260
10,055,536
10,028,087
9,977,375
10,182,541
10,059,715
10,196,149
9,956,653
9,729,222
9,974,072
10,411,278
10,038,777
9,778,077
9,778,07710,038,77710,411,2789,974,0729,729,2229,956,65310,196,14910,059,71510,182,5419,977,37510,028,08710,055,53611,057,26010,898,57112,505,99510,727,64812,085,06612,698,43013,254,14312,028,67411,581,22312,126,71111,957,22110,802,2779,616,86711,034,39710,609,1989,393,4007,380,8016,548,0326,634,4966,796,5876,840,6346,666,0106,963,5986,344,4035,732,7434,845,6724,662,1464,010,8223,913,6564,049,0313,589,0823,073,4022,721,5662,439,3632,259,8642,102,1732,268,7922,082,2461,960,6931,835,4221,772,6171,525,8011,504,8911,357,8751,300,6341,225,9511,185,1981,041,152917,971992,076920,122752,781884,655866,750950,7611,054,003950,926874,1001,225,6201,322,0261,341,4571,433,599541,1091,589,3141,232,288987,834846,912756,392758,1911,163,2451,178,8401,119,6001,072,940998,7451,017,096380,669235,28144,825093,30832,73911,16310,1009,5642,2222,44313,433
       Other Current Liabilities 
40,426
2,923
1,462
169,503
33
1
-532
11,603
1,122,290
2,227
3,814
12,441
8,324
7,993
12,627
201,617
17,909
22,885
16,872
137,395
12,893
61,354
36,065
205,629
2,768,667
144,145
145,511
54,103
11,931
15,312
16,347
41,933
36,811
149,202
103,484
123,572
101,289
105,505
71,349
78,668
94,034
71,013
59,752
42,368
42,850
42,218
29,522
22,047
53,478
48,282
41,722
46,495
60,941
28,217
213,727
60,488
39,530
79,980
122,040
60,977
85,925
70,982
109,105
68,622
51,219
49,894
56,179
77,247
64,795
95,715
1,627,918
2,738,239
2,778,231
1,854,196
532,713
370,804
379,316
445,888
357,413
444,006
154,200
138,566
115,356
250,573
196,718
958,541
1,030,143
282,404
7,493,454
7,413,470
6,789,750
7,308,020
7,127,498
415,033
433,951
472,572
406,485
411,016
415,153
415,153411,016406,485472,572433,951415,0337,127,4987,308,0206,789,7507,413,4707,493,454282,4041,030,143958,541196,718250,573115,356138,566154,200444,006357,413445,888379,316370,804532,7131,854,1962,778,2312,738,2391,627,91895,71564,79577,24756,17949,89451,21968,622109,10570,98285,92560,977122,04079,98039,53060,488213,72728,21760,94146,49541,72248,28253,47822,04729,52242,21842,85042,36859,75271,01394,03478,66871,349105,505101,289123,572103,484149,20236,81141,93316,34715,31211,93154,103145,511144,1452,768,667205,62936,06561,35412,893137,39516,87222,88517,909201,61712,6277,9938,32412,4413,8142,2271,122,29011,603-532133169,5031,4622,92340,426
   > Long-term Liabilities 
2,922
2,410
3,241
3,090
2,447
2,000
5,600
0
-1,122,290
100
100
18,927
17,286
16,276
21,839
7,000
7,000
7,000
7,000
3,000
8,000
3,000
4,000
1,000
0
131,000
131,000
128,000
166,631
139,661
125,000
125,344
121,800
114,800
114,800
204,820
197,320
179,820
172,320
126,707
125,107
115,378
116,287
64,530
64,776
1,980
167
8,501
5,500
5,503
5,500
5,040
2,047
2,909
2,917
14,309
13,347
12,614
7,513
69,407
69,770
67,436
20,061
185,241
185,801
191,112
188,605
164,809
159,824
898,751
1,741,945
1,741,268
2,799,966
2,764,570
4,495,949
3,421,710
3,917,797
3,431,221
3,382,395
1,490,379
1,665,285
708,308
705,749
359,252
558,486
565,840
639,799
533,910
548,182
595,609
566,211
447,903
398,585
398,703
374,309
358,883
392,667
418,563
436,894
436,894418,563392,667358,883374,309398,703398,585447,903566,211595,609548,182533,910639,799565,840558,486359,252705,749708,3081,665,2851,490,3793,382,3953,431,2213,917,7973,421,7104,495,9492,764,5702,799,9661,741,2681,741,945898,751159,824164,809188,605191,112185,801185,24120,06167,43669,77069,4077,51312,61413,34714,3092,9172,9092,0475,0405,5005,5035,5008,5011671,98064,77664,530116,287115,378125,107126,707172,320179,820197,320204,820114,800114,800121,800125,344125,000139,661166,631128,000131,000131,00001,0004,0003,0008,0003,0007,0007,0007,0007,00021,83916,27617,28618,927100100-1,122,29005,6002,0002,4473,0903,2412,4102,922
       Other Liabilities 
0
0
0
0
1
0
3,600
0
110
101
100
1
0
0
1,588
2,000
2,000
2,000
2,000
3,000
3,000
3,001
4,000
1,000
1,000
999
1,000
1,000
1,000
999
1,725
1,000
1,801
1,800
1,800
820
820
820
819
2,628
1,029
3,328
3,329
2,470
2,670
1,920
130
8,470
5,470
5,470
5,469
5,010
2,010
2,877
2,877
12,385
13,305
12,576
7,462
69,357
69,195
67,321
19,994
185,116
185,715
191,015
188,515
140,406
140,172
89,653
89,419
38,516
37,364
35,080
1,939,335
47,270
46,864
349,922
349,511
130,936
130,748
123,598
165,002
198,684
165,891
175,429
213,942
157,068
153,724
146,037
138,701
41,147
0
38,183
37,582
0
0
0
0
000037,58238,183041,147138,701146,037153,724157,068213,942175,429165,891198,684165,002123,598130,748130,936349,511349,92246,86447,2701,939,33535,08037,36438,51689,41989,653140,172140,406188,515191,015185,715185,11619,99467,32169,19569,3577,46212,57613,30512,3852,8772,8772,0105,0105,4695,4705,4708,4701301,9202,6702,4703,3293,3281,0292,6288198208208201,8001,8001,8011,0001,7259991,0001,0001,0009991,0001,0004,0003,0013,0003,0002,0002,0002,0002,0001,58800110010111003,600010000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,600
151,115
172,557
176,795
176,618
185,265
181,684
178,731
178,633
180,640
178,206
154,642
157,965
159,790
159,018
163,283
154,215
157,038
0
154,818
150,833
151,271
0
0
0
0
0000151,271150,833154,8180157,038154,215163,283159,018159,790157,965154,642178,206180,640178,633178,731181,684185,265176,618176,795172,557151,115138,6000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
71,405
176,319
203,078
204,738
232,472
235,711
1,673,002
1,666,445
1,648,340
1,676,806
1,683,783
1,690,138
1,675,384
1,697,421
1,707,929
1,410,305
1,745,647
1,768,819
1,772,880
1,396,449
1,633,669
1,540,899
1,588,456
689,326
697,238
702,792
707,013
716,327
688,488
705,477
721,716
747,891
713,629
742,629
742,205
703,196
708,269
694,894
682,168
629,532
647,995
661,583
671,946
741,707
765,922
783,188
791,711
791,741
817,384
844,286
853,441
843,364
1,440,258
1,465,510
1,465,939
1,522,411
1,471,931
1,468,174
1,471,093
1,437,947
1,466,665
1,673,325
1,829,979
1,804,383
1,863,294
4,914,891
5,068,788
5,366,055
5,456,671
5,497,112
5,647,814
5,517,188
5,667,044
5,841,138
5,946,261
5,982,983
6,449,002
6,252,472
6,376,851
6,256,211
6,339,850
6,382,302
6,454,228
5,878,795
5,970,291
5,850,635
5,924,245
5,822,127
5,893,059
5,925,871
5,943,391
4,690,954
4,755,846
4,769,809
4,770,612
3,002,923
3,045,564
3,047,542
3,035,898
3,035,8983,047,5423,045,5643,002,9234,770,6124,769,8094,755,8464,690,9545,943,3915,925,8715,893,0595,822,1275,924,2455,850,6355,970,2915,878,7956,454,2286,382,3026,339,8506,256,2116,376,8516,252,4726,449,0025,982,9835,946,2615,841,1385,667,0445,517,1885,647,8145,497,1125,456,6715,366,0555,068,7884,914,8911,863,2941,804,3831,829,9791,673,3251,466,6651,437,9471,471,0931,468,1741,471,9311,522,4111,465,9391,465,5101,440,258843,364853,441844,286817,384791,741791,711783,188765,922741,707671,946661,583647,995629,532682,168694,894708,269703,196742,205742,629713,629747,891721,716705,477688,488716,327707,013702,792697,238689,3261,588,4561,540,8991,633,6691,396,4491,772,8801,768,8191,745,6471,410,3051,707,9291,697,4211,675,3841,690,1381,683,7831,676,8061,648,3401,666,4451,673,002235,711232,472204,738203,078176,31971,405
   Common Stock
57,300
76,400
152,800
152,800
152,800
152,800
221,800
221,800
0
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
332,700
475,008
475,008
475,008
475,008
617,510
617,510
617,510
617,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
652,510
731,714
731,714
731,714
731,714
731,714
731,714
731,714
731,714
731,714
752,514
752,514
752,514
752,514
2,646,591
2,648,286
2,648,211
2,648,211
2,648,211
2,646,613
2,646,613
2,646,613
2,646,613
2,646,613
2,646,613
2,762,583
2,762,583
2,762,583
2,762,583
2,762,583
2,762,583
2,762,583
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
2,750,833
0
0
002,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,750,8332,762,5832,762,5832,762,5832,762,5832,762,5832,762,5832,762,5832,646,6132,646,6132,646,6132,646,6132,646,6132,646,6132,648,2112,648,2112,648,2112,648,2862,646,591752,514752,514752,514752,514731,714731,714731,714731,714731,714731,714731,714731,714731,714652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510652,510617,510617,510617,510617,510475,008475,008475,008475,008332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,700332,7000221,800221,800152,800152,800152,800152,80076,40057,300
   Retained Earnings 
14,103
18,407
29,886
26,886
50,460
48,630
80,186
48,784
0
60,765
69,281
73,819
61,659
89,104
100,661
-212,106
104,307
123,922
127,856
-193,122
40,307
-55,152
-36,320
-935,008
0
-916,474
-907,890
-892,538
-932,469
-915,280
-899,041
-914,907
-911,588
-882,587
-883,011
-896,327
-891,255
-876,470
-870,563
-1,050,666
-1,032,203
-1,017,434
-1,010,229
-1,003,997
-980,044
-962,003
-953,113
-951,469
-927,272
-900,631
-891,309
-892,402
-867,308
-841,050
-833,953
-775,354
-748,589
-722,420
-721,233
-751,563
-724,014
-696,427
-400,843
-276,830
-237,479
-176,695
-49,079
141,565
233,463
377,221
552,584
574,770
724,626
898,720
1,003,843
1,014,434
1,110,182
1,126,619
1,288,399
1,179,982
1,257,371
1,306,343
1,378,555
891,451
983,889
1,032,610
1,106,088
985,688
1,056,620
1,099,432
1,117,594
-41,687
32,844
45,992
46,795
-1,730,617
-1,687,975
-1,685,207
-1,684,399
-1,684,399-1,685,207-1,687,975-1,730,61746,79545,99232,844-41,6871,117,5941,099,4321,056,620985,6881,106,0881,032,610983,889891,4511,378,5551,306,3431,257,3711,179,9821,288,3991,126,6191,110,1821,014,4341,003,843898,720724,626574,770552,584377,221233,463141,565-49,079-176,695-237,479-276,830-400,843-696,427-724,014-751,563-721,233-722,420-748,589-775,354-833,953-841,050-867,308-892,402-891,309-900,631-927,272-951,469-953,113-962,003-980,044-1,003,997-1,010,229-1,017,434-1,032,203-1,050,666-870,563-876,470-891,255-896,327-883,011-882,587-911,588-914,907-899,041-915,280-932,469-892,538-907,890-916,4740-935,008-36,320-55,15240,307-193,122127,856123,922104,307-212,106100,66189,10461,65973,81969,28160,765048,78480,18648,63050,46026,88629,88618,40714,103
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000-56,332-56,332-56,332-56,332-56,332-56,332-108,117-108,117-168,688-168,688-168,688-168,688000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
2
81,511
20,391
25,052
29,212
34,282
1,371,016
1,395,861
0
1,283,340
1,281,802
1,283,619
1,281,026
1,275,617
1,274,568
1,289,711
1,308,640
1,312,197
1,312,324
1,256,871
1,260,662
1,263,351
1,292,076
1,291,633
697,238
1,144,259
1,139,895
1,133,856
1,145,949
1,003,247
1,003,247
1,045,287
1,007,706
972,706
972,706
947,013
947,013
918,853
900,221
1,027,688
1,027,688
1,026,507
1,029,665
1,093,193
1,093,456
1,092,681
1,092,313
1,090,700
1,092,146
1,092,406
1,092,239
1,083,256
1,575,852
1,574,846
1,568,179
1,566,051
1,488,807
1,458,880
1,460,612
1,457,796
1,458,966
1,617,238
1,478,308
1,328,699
1,348,259
2,444,996
2,469,581
2,576,279
2,574,997
2,471,680
2,448,618
2,295,805
2,295,805
2,295,805
2,295,805
2,321,937
2,576,237
2,363,271
2,325,869
2,313,646
2,319,896
2,313,376
2,313,089
2,236,511
2,235,569
2,067,192
2,067,324
4,483,429
2,085,606
1,900,644
-275,118
1,805,268
-275,118
1,805,268
-275,118
1,967,368
1,967,368
0
0
001,967,3681,967,368-275,1181,805,268-275,1181,805,268-275,1181,900,6442,085,6064,483,4292,067,3242,067,1922,235,5692,236,5112,313,0892,313,3762,319,8962,313,6462,325,8692,363,2712,576,2372,321,9372,295,8052,295,8052,295,8052,295,8052,448,6182,471,6802,574,9972,576,2792,469,5812,444,9961,348,2591,328,6991,478,3081,617,2381,458,9661,457,7961,460,6121,458,8801,488,8071,566,0511,568,1791,574,8461,575,8521,083,2561,092,2391,092,4061,092,1461,090,7001,092,3131,092,6811,093,4561,093,1931,029,6651,026,5071,027,6881,027,688900,221918,853947,013947,013972,706972,7061,007,7061,045,2871,003,2471,003,2471,145,9491,133,8561,139,8951,144,259697,2381,291,6331,292,0761,263,3511,260,6621,256,8711,312,3241,312,1971,308,6401,289,7111,274,5681,275,6171,281,0261,283,6191,281,8021,283,34001,395,8611,371,01634,28229,21225,05220,39181,5112



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue36,418,770
Cost of Revenue-32,865,445
Gross Profit3,553,3253,553,325
 
Operating Income (+$)
Gross Profit3,553,325
Operating Expense-35,533,231
Operating Income885,539-31,979,906
 
Operating Expense (+$)
Research Development47,938
Selling General Administrative1,757,636
Selling And Marketing Expenses0
Operating Expense35,533,2311,805,574
 
Net Interest Income (+$)
Interest Income48,791
Interest Expense-945,945
Other Finance Cost-46,468
Net Interest Income-943,622
 
Pretax Income (+$)
Operating Income885,539
Net Interest Income-943,622
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,458,474885,539
EBIT - interestExpense = -945,945
-1,689,945
-744,000
Interest Expense945,945
Earnings Before Interest and Taxes (EBIT)0-512,530
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,458,474
Tax Provision-260,559
Net Income From Continuing Ops-1,719,033-1,719,033
Net Income-1,689,945
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0943,622
 

Technical Analysis of Shenzhen Neptunus Bioengineering Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shenzhen Neptunus Bioengineering Co Ltd. The general trend of Shenzhen Neptunus Bioengineering Co Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shenzhen Neptunus Bioengineering Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Shenzhen Neptunus Bioengineering Co Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shenzhen Neptunus Bioengineering Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.54 < 2.55 < 2.55.

The bearish price targets are: 2.29 > 2.29 > 2.28.

Know someone who trades $000078? Share this with them.👇

Shenzhen Neptunus Bioengineering Co Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shenzhen Neptunus Bioengineering Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shenzhen Neptunus Bioengineering Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shenzhen Neptunus Bioengineering Co Ltd. The current macd is -0.00151725.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shenzhen Neptunus Bioengineering Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Shenzhen Neptunus Bioengineering Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Shenzhen Neptunus Bioengineering Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shenzhen Neptunus Bioengineering Co Ltd. The current adx is 14.38.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shenzhen Neptunus Bioengineering Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shenzhen Neptunus Bioengineering Co Ltd. The current sar is 2.34382082.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shenzhen Neptunus Bioengineering Co Ltd. The current rsi is 52.46. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Relative Strength Index (RSI) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shenzhen Neptunus Bioengineering Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shenzhen Neptunus Bioengineering Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Stochastic Oscillator ChartShenzhen Neptunus Bioengineering Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shenzhen Neptunus Bioengineering Co Ltd. The current cci is 35.70.

Shenzhen Neptunus Bioengineering Co Ltd Daily Commodity Channel Index (CCI) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shenzhen Neptunus Bioengineering Co Ltd. The current cmo is 11.36.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shenzhen Neptunus Bioengineering Co Ltd. The current willr is -40.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shenzhen Neptunus Bioengineering Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shenzhen Neptunus Bioengineering Co Ltd Daily Williams %R ChartShenzhen Neptunus Bioengineering Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shenzhen Neptunus Bioengineering Co Ltd.

Shenzhen Neptunus Bioengineering Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shenzhen Neptunus Bioengineering Co Ltd. The current atr is 0.0681053.

Shenzhen Neptunus Bioengineering Co Ltd Daily Average True Range (ATR) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shenzhen Neptunus Bioengineering Co Ltd. The current obv is 274,404,987.

Shenzhen Neptunus Bioengineering Co Ltd Daily On-Balance Volume (OBV) ChartShenzhen Neptunus Bioengineering Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shenzhen Neptunus Bioengineering Co Ltd. The current mfi is 58.28.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shenzhen Neptunus Bioengineering Co Ltd Daily Money Flow Index (MFI) ChartShenzhen Neptunus Bioengineering Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shenzhen Neptunus Bioengineering Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Shenzhen Neptunus Bioengineering Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shenzhen Neptunus Bioengineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.455
Ma 20Greater thanMa 502.410
Ma 50Greater thanMa 1002.433
Ma 100Greater thanMa 2002.637
OpenGreater thanClose2.410
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Shenzhen Neptunus Bioengineering Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Shenzhen Neptunus Bioengineering Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shenzhen Neptunus Bioengineering Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shenzhen Neptunus Bioengineering Co Ltd

I send you an email if I find something interesting about Shenzhen Neptunus Bioengineering Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shenzhen Neptunus Bioengineering Co Ltd.

Receive notifications about Shenzhen Neptunus Bioengineering Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.